Testing effectiveness (Phase 2)Ended earlyNCT00058461
What this trial is testing
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Burkitt LymphomaChildhood Diffuse Large Cell Lymphoma+6 more
National Cancer Institute (NCI) 82